Harrow Health, Inc. (HROW) Financials
HROW Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| June 30, 2026 | 416.8 million | 402.0 million |
| March 31, 2026 | 419.5 million | 391.2 million |
| Dec. 31, 2025 | 399.5 million | 347.4 million |
| Sept. 30, 2025 | 363.1 million | 316.4 million |
HROW Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| June 30, 2026 | -9.6 million | -3.8 million |
| March 31, 2026 | -9.2 million | 3.8 million |
| Dec. 31, 2025 | 8.1 million | 3.8 million |
| Sept. 30, 2025 | 16.4 million | 3.3 million |
HROW Net Income
No data available :(
HROW Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| June 30, 2026 | 83.9 million | 292.4 million | 8.4 million |
| March 31, 2026 | 94.6 million | 292.1 million | 7.7 million |
| Dec. 31, 2025 | 72.9 million | 243.2 million | 8.8 million |
| Sept. 30, 2025 | 74.3 million | 242.9 million | 9.0 million |
HROW Shares Outstanding
HROW Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| June 30, 2026 | 194000 | 8.1 million | 53.3 million | - |
| March 31, 2026 | 194000 | 5.9 million | 43.2 million | - |
| Dec. 31, 2025 | 341000 | 3.3 million | 43.3 million | - |
| Sept. 30, 2025 | 225000 | 3.3 million | 35.9 million | - |
HROW Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| June 30, 2026 | 70.7 million | 20.3 million |
| March 31, 2026 | 44.2 million | 17.2 million |
| Dec. 31, 2025 | 89.1 million | 18.5 million |
| Sept. 30, 2025 | 71.6 million | 17.7 million |
HROW Revenue by Segment
Graph available only for paid members. Upgrade to see it.
HROW
Price: $28.75
52 week price:
Payout Ratio Range:
Earnings Per Share: -0.99 USD
Exchange: NGM
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Country: United States
Volume: 114053
Market Capitalization: 1.1 billion